Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of citalopram in schizophrenia
IRCT20180619040161N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citalopram in schizophrenia, sponsored by Urmia University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
citalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20180619040161N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180619040161N1.